Dr. David Dexter talks about• His job as a NeuroPharmacologist
• What is meant by the term neuroscience
• The challenges of developing better treatments for diseases like Alzheimer’s and Parkinson’s
• Why neuroscience is the next big challenge
• What we know about the brain
• The ethical challenges for society around scientific developments in relation to the brain
About Dr. David DexterReader in NeuroPharmacology,Dept of Medicine
Dr David Dexter is a neuropharmacologist who has been involved in Parkinson’s disease research for the past 26 years. His gained his BSc in Pharmacology from the University of Bradford and his PhD in Neuropharmacology from King’s College.
In 1994 he attained a lectureship position at Imperial College London, where he has subsequently developed his research facility. In 2002 he was instrumental in setting up the Parkinson’s UK Tissue Bank at Imperial which runs a prospective tissue donor scheme to help foster research into Parkinson’s disease. His research interests involve understanding the disease mechanisms that cause Parkinson’s disease and helping develop effective treatment strategies.